Previous Close | 561.69 |
Open | 559.99 |
Bid | 554.23 x 800 |
Ask | 600.00 x 800 |
Day's Range | 550.94 - 562.70 |
52 Week Range | 475.77 - 618.36 |
Volume | |
Avg. Volume | 1,418,866 |
Market Cap | 213.617B |
Beta (5Y Monthly) | 0.79 |
PE Ratio (TTM) | 31.42 |
EPS (TTM) | 17.64 |
Earnings Date | Apr 26, 2023 - May 01, 2023 |
Forward Dividend & Yield | 1.40 (0.25%) |
Ex-Dividend Date | Mar 14, 2023 |
1y Target Est | 649.59 |
Subscribe to Yahoo Finance Plus to view Fair Value for TMO
Thermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies.
Over the past year, many Thermo Fisher Scientific Inc. ( NYSE:TMO ) insiders sold a significant stake in the company...
Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys are included in this Analyst Blog.